Blog
890 Articles

World Pancreatic Cancer Coalition Members Demand Better on World Pancreatic Cancer Day
World Pancreatic Cancer Coalition members come together on World Pancreatic Cancer Day to demand better for patients, treatments, early detection, research.

Let’s Win and the Lustgarten Foundation Demand Better for World Pancreatic Cancer Day
Cindy Gavin of Let’s Win and Kerri Kaplan of the Lustgarten Foundation demand better for treatments and research on World Pancreatic Cancer Day.

Cindy Gavin Demands Better for World Pancreatic Cancer Day
Cindy Gavin, Founding Executive Director of Let’s Win, demands better treatment options for World Pancreatic Cancer Day in this PSA.

Trying Targeted Treatments Used for Other Cancers
Researchers are trying kinase inhibitors that are effective for breast cancer, colorectal cancer, and melanoma on pancreatic cancer.

Standard of Care Plus
Dr. Allyson Ocean explains why pancreatic cancer patients should consider clinical trials, which go beyond standard of care.

Testing a Breast Cancer Drug for Other Advanced Solid Tumors
In a clinical trial, a new class of breast cancer drug called a kinase inhibitor is being tested to treat pancreatic cancer.

Frequently Asked Questions About Pancreatic Cancer
Have you or someone you love just been diagnosed with pancreatic cancer? Learn some basic facts about this disease from our FAQ.

More Research Needed for Pancreatic Cancer Immunotherapy
Dr. Luis Diaz provides a status check for immunotherapy treatments for pancreatic cancer, including an explanation of different types.

Novel Drug Combination Plus Radiation for Locally Advanced Pancreatic Cancer
A clinical trial combines immunotherapy, common treatments, an antiretroviral drug, and SBRT for locally advanced pancreatic cancer.

Tumor Genetics Research Brings Some Answers for Families at High Risk
Professor Gloria Peterson of the Mayo Clinic is working on tumor genetics to help make early detection of pancreatic cancer a reality.

Investigating a Drug Used for Other Cancers
In a clinical trial, researchers are adding the drug decitabine to gemcitabine, for patients with advanced cancer that is not responding to treatment.